The impact of coronavirus disease 2019 (COVID-19) response on central-line–associated bloodstream infections and blood culture contamination rates at a tertiary-care center in the Greater Detroit area
Jennifer LeRose, Avnish Sandhu, Jordan Polistico, J.M. Ellsworth, Mara Cranis, Lavina Jabbo, Lori M. Cullen, Judy Moshos, Lobelia Samavati, Teena Chopra
Abstract
We conducted a comparative retrospective study to quantify the impact of coronavirus disease 2019 (COVID-19) on patient safety. We found a statistically significant increase in central-line-associated bloodstream infections and blood culture contamination rates during the pandemic. Increased length of stay and mortality were also observed during the COVID-19 pandemic.
Topics & Concepts
PandemicMedicineCoronavirusTertiary careCoronavirus disease 2019 (COVID-19)Blood cultureBloodstream infectionSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Central lineRetrospective cohort studyVirology2019-20 coronavirus outbreakEmergency medicineDiseaseIntensive care medicineInternal medicineInfectious disease (medical specialty)MicrobiologyOutbreakBiologyAntibioticsSepsis Diagnosis and TreatmentCentral Venous Catheters and HemodialysisAntibiotic Use and Resistance